The stock market has been on edge since the announcement of tariffs, reporting its biggest loss since March 2020. The damage ...

Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

Jim Cramer in a latest program on CNBC urged investors to start accepting the reality of the new economic system under ...

Mounjaro weight-loss injection pens should contain four doses, but some users are managing to get a fifth dose out of the devices. Experts are warning against this ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

A new analysis of FDA adverse event reports suggests a potential link between tirzepatide and thyroid cancer. Learn what this ...

The telehealth company is offering Lilly’s branded form of tirzepatide—approved for weight loss—on its site for $1,899 a ...